Enteral Feeding Devices Market

Fresenius Kabi and Nestle SA are the leading players in the enteral feeding devices market

The enteral feeding devices market is projected to reach $4.4 billion by 2025 from $3.2 billion in 2020, at a CAGR of 6.8% during the forecast period. The enteral feeding devices market has evolved significantly owing to various technological advancements, such as programming and safety features in feeding pumps as well as user-friendly and portable feeding pumps. Factors such as rising healthcare costs; surge in the number of preterm births; growth in the aging population; rising prevalence of chronic diseases such as diabetes, cancer, gastrointestinal diseases, and neurological disorders; growing awareness of enteral nutrition; and rapid improvements in healthcare facilities in emerging countries are expected to further drive the market during the forecast period also propelling the growth of the enteral feeding market.

The enteral feeding devices market consolidated at the top with a large number of leading market players based in developed countries. The prominent players in this market are Fresenius Kabi AG (Germany), Avanos Medical, Inc. (US), Cardinal Health, Inc. (US), B. Braun Melsungen AG (Germany), Abbott Laboratories (US), Becton, Dickinson and Company (US), Boston Scientific Corporation (US), Cook Medical, Inc. (US), CONMED Corporation (CONMED) (US), Nestlé S.A. (Switzerland), Danone (France), Moog, Inc. (US), Vygon (France), Amsino International (US), and Applied Medical Technology, Inc. (US).Due to the intense competition in the market, major players are increasingly focusing on expanding their geographic presence in high-growth emerging markets and strengthening their technological competitiveness by acquiring smaller players with the desired technological capabilities or geographic presence. Market players are also focusing on acquiring local players to expand their portfolios and enhance their distribution channels in regional markets.

To know about the assumptions considered for the study download the pdf brochure

Fresenius is a global healthcare company that provides products and services for hospitals and home care settings, along with outpatient medical care. The company operates through four major business segments—Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. Fresenius Kabi is a wholly-owned subsidiary of Fresenius SE & Co. KGaA. The company is engaged in the development, manufacturing, and marketing of pharmaceutical products and medical devices. Kabi operates in four business segments, namely, IV Drugs, Clinical Nutrition, Infusion Therapy, and Medical Devices/Transfusion Technology. The companys product portfolio includes intravenously administered drugs, infusion therapy products, medical devices, and clinical nutrition products. Its products and services are used for the treatment of critically and chronically ill patients. The enteral feeding products offered under the Fresenius Kabi segment include feeding devices and nutritional supplements. The company conducts sales and marketing operations of about 100 different product groups in over 160 countries across Europe, North America, the Asia Pacific, Latin America, and Africa through direct offices. Some of its major subsidiaries are Fresenius Kabi Austria GmbH, Fresenius Kabi Deutschland GmbH (Germany), Novartis Nutrition S.A.S. (France), Fresenius Kabi Asia Pacific Ltd. (Hong Kong), and V.Krutten Medizinische Einmalgerate GmbH (Germany).

Nestlé is a multinational nutrition, health, and wellness company that manufactures and markets milk-based products, pharmaceuticals, ophthalmic goods, baby foods and cereals, and cooking aids. The company’s business segments include Powdered and Liquid Beverages, Milk Products and Ice Cream, Nutrition and Health Science, Prepared Dishes and Cooking Aids, Confectionery, Water, and PetCare.

Nestlé Health Science, a division of Nestlé Group, is engaged in the development, manufacturing, and marketing of science-based nutritional solutions (clinical nutrition) in the areas of consumer care, medical nutrition, and novel therapeutic nutrition. This segment provides enteral feeding devices. Nestlé Health Science has a strong foothold in North America, Europe, South America, and Asia. The company operates in 190 countries—Zone EMENA (Europe, Middle East, and North Africa), Zone Americas (AMS), Zone Asia, Oceania, & Africa (AOA)—and has 442 factories in over 86 countries. As of 2018, Nestlé Health Science had more than 3,000 employees. Some of Nestlé’s notable subsidiaries are Nestlé HealthCare Nutrition, Inc. (US), Wyeth Nutritional (China) Co., Ltd., Wyeth Nutritionals (Singapore) Pte Ltd., Nestlé UK, Nestlé India, Nestlé Canada, and Nestlé Japan.

Related Reports:

Enteral Feeding Devices Market By Type (Feeding Pump, Feeding Tube, Giving Set, Syringes), Age Group (Adult, Pediatric), Application (Oncology, Diabetes, Hypermetabolism), End User (Hospital, Home Care), COVID-19 Impact - Global Forecast To 2025

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Report Code
MD 1289
RI Published ON
Choose License Type
Request Customization
Speak to Analyst
Speak to Analyst
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
  • What are the Known and Unknown Adjacencies Impacting the Enteral Feeding Devices Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
©2021 MarketsandMarkets Research Private Ltd. All rights reserved